Cision PR Newswire

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand

SHENZHEN, China, Oct. 31, 2026 /PRNewswire/ -- SKYWORTH Solar has officially announced the global launch of Solavita, its dedicated brand for smart microgrid solutions. Positioned strategically as "A Smart Microgrid Expert for Diverse Energy Scenarios," Solavita consolidates the company's extensive solution portfolio and service infrastructure under a unified global...

GAC Wins 8 Awards, Including 4 First Prizes, Showcasing Technological Innovation Strength

SUZHOU, China, Oct. 31, 2026 /PRNewswire/ -- On October 28, GAC won 8 awards at...

Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.

SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced today...

ScienceOra Demonstrates AI-Assisted Hydrogen-Production Catalyst Design Workflow at Tencent Global Digital Ecosystem Summit

The workflow spans literature analysis, candidate design, experimental planning and industrial decision support, extending...

Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies

SAN FRANCISCO and SUZHOU, China, April 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures,...

137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinking

GUANGZHOU, China, April 30, 2025 /PRNewswire/ -- Phase 2 of the 137th China Import and Export Fair (Canton Fair), taking place from April 23...

Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong

SHANGHAI, April 30, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development,...

KT Corp. Files 2024 Annual Report on Form 20-F

SEOUL, South Korea, April 30, 2025 /PRNewswire/ -- KT Corporation (NYSE: KT), South Korea's leading integrated telecommunications and platform service provider, announced that it has filed its...

【C.S Group】: Launches Antcin A-Based Veterinary Drug Initiative Across Taiwan and China

TAIPEI, April 30, 2025 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S Group】 announced a major milestone in veterinary drug development at the "Pharmacological...